PYRAMID POINTS CHAPTER 62: RENAL MEDICATIONS. ADULT HEALTH: Renal Medications Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier.

Slides:



Advertisements
Similar presentations
Gastrointestinal Medications
Advertisements

Chapter 19 Hematologic Products.
Introduction to Clinical Pharmacology Chapter 9 Antibacterial Drugs That Interfere With DNA/RNA Synthesis.
Medications Post Lung Transplant Stacey Balducci, Pharm.D. Office: (212) Liver Transplant Pharmacist.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 8 Antiinfective Agents.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 69 Immunosuppressants.
New Developments in the Management of Kidney Transplant Patients
Familial metabolic disease Characterized by : Acute arthritis Uric stones in the kidneys Hyperuricemia.
Chapter 5 Autonomic Drugs.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 14 Muscarinic Agonists and Antagonists.
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 45 Immunosuppressant Drugs.
Sulfonamides, trimethoprim and Quinolones
CHAPTER 76: PSYCHIATRIC MEDICATIONS
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 6 Nonopiod (Nonnarcotic) Analgesics.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 18 Nonopioid Analgesics: Nonsteroidal Anti-Inflammatory Drugs.
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. Chapter 87 Sulfonamides and Trimethoprim.
PYRAMID POINTS CHAPTER 64: OPHTHALMIC AND OTIC MEDICATIONS.
Quinolones Folic Acid Antagonists Urinary Tract Antiseptics.
Medications for the Treatment of Infections. Antibiotic vs. Antibacterial Used interchangeably Origin of antibiotic includes any antimicrobial agent Antibacterial.
Chapter 10 Diseases of the Urinary System. Elsevier items and derived items © 2009 by Saunders, an imprint of Elsevier Inc. 1 Organs and Function  Kidneys.
Immunosuppressant Drugs
Chapter 15 Urinary System Drugs. 2 Diuretics Increase urine excretion Categories –Thiazides –Loop diuretics –Potassium-sparing diuretics –Osmotic agents.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 41 Antifungal Drugs.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 21 Positive Inotropic Drugs.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 17 Nonopioid Analgesics: Salicylates and Nonsalicylates.
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. Chapter 90 Miscellaneous Antibacterial Drugs: Fluoroquinolones, Metronidazole,
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 19 Cholinergic Drugs.
Urinary Antiseptics. Organisms  Escherichia coli  Proteus  Pseudomonas species  streptococci  Klebsiella  Enterococcus  Staphylococcus epidermidis.
Drugs Used to Treat Disorders of the Urinary System Chapter 42 Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier.
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 20 Cholinergic Drugs.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 8 Cephalosporins.
PYRAMID POINTS CHAPTER 56: GASTROINTESTINAL MEDICATIONS.
Drugs Used for Diuresis Chapter 29 Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
PYRAMID POINTS CHAPTER 60: CARDIOVASCULAR MEDICATIONS.
Drugs Affecting the Autonomic Nervous System
 The ARBs include the following drugs:  azilsartan (Edarbi),candesartan (Atacand), eprosartan (Teveten), irbesartan(Avapro), losartan (Cozaar), olmesartan.
PYRAMID POINTS CHAPTER 68: MUSCULOSKELETAL MEDICATIONS.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 45 Immunosuppressant Drugs.
Drugs Used to Treat Gastroesophageal Reflux and Peptic Ulcer Diseases
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 10 Fluoroquinolones and Aminoglycosides.
Mycophenolate Mofetil Mshael AL-Bargawi
Adult Medical-Surgical Nursing Renal Module: Urinary Tract Infection.
- nonsteroidal anti-inflammatory drugs (NSAIDs), are used to combat inflammation. - Their antiinflammatory action equals that of aspirin. - have analgesic.
Cardiac Stimulants and Depressants
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 11 Miscellaneous Anti-Infectives.
Elsevier items and derived items © 2009 by Saunders, an imprint of Elsevier Inc. Some material was previously published. 1 Unit 3 Seminar Dr. Amy Thompson.
Elsevier items and derived items © 2009 by Saunders, an imprint of Elsevier Inc. Some material was previously published. Slide 0 Chapter 9 Calculating.
IMMUNOSUPPRESSANT THERAPY DR FATAI OLUYADI USMLEINCLINED.COM 1.
Copyright © 2016, 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. Care of Patients with Urinary Problems.
Transplant Medications Ed Horn, Pharm.D., BCPS Clinical Pharmacy Specialist – Transplant Allegheny General Hospital.
History of Kidney Transplantation
Chapter 30 Drugs used to treat urinary system disorders
Focus on Pharmacology Essentials for Health Professionals
Focus on Pharmacology Essentials for Health Professionals
Renal Medications 1.
Miscellaneous Antibiotics
Immunosuppressant Drugs
Drugs for Autonomic Nervous System
Introduction to Clinical Pharmacology Chapter 9 Antibacterial Drugs That Interfere With DNA/RNA Synthesis.
Introduction to Sulfonamides
CHAPTER 66: NEUROLOGICAL MEDICATIONS
Musculoskeletal Pharmacology
Chapter 5 Autonomic Drugs.
Introduction to Clinical Pharmacology Chapter 48 Urinary Tract Anti-Infectives and Other Urinary Drugs.
Cholinesterase Inhibitors: Actions and Uses
Introduction to Clinical Pharmacology Chapter 9 Antibacterial Drugs That Interfere With DNA/RNA Synthesis.
Introduction to Clinical Pharmacology Chapter 16 Opioid Antagonists
Antibacterial Drugs: Sulfonamides
Cholinergic Blocking Drugs: Actions
Introduction to Clinical Pharmacology Chapter 26 Cholinergic Drugs
Presentation transcript:

PYRAMID POINTS CHAPTER 62: RENAL MEDICATIONS

ADULT HEALTH: Renal Medications Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc.62-2 PYRAMID POINTS I. Urinary Tract Antiseptics  Description Inhibit growth of bacteria in urine Inhibit growth of bacteria in urine  Side effects and nursing considerations Cinoxacin (Cinobac) Cinoxacin (Cinobac)  Dosages should be reduced in clients with renal impairment. Methenamine (Mandelamine, Hiprex, Urex) Methenamine (Mandelamine, Hiprex, Urex)  Requires acidic urine with pH of 5.5 or lower  Increasing fluids reduces antibacterial effects  Should not be combined with sulfonamides  Clients should avoid alkalinizing agents, including antacids

ADULT HEALTH: Renal Medications Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc.62-3 PYRAMID POINTS I. Urinary Tract Antiseptics (continued)  Nalidixic acid (NegGram) May produce intracranial hypertension in pediatric clients May produce intracranial hypertension in pediatric clients Can intensify effects of orally administered anticoagulants Can intensify effects of orally administered anticoagulants  Nitrofurantoin (Furadantin, Macrodantin, Macrobid) May cause pulmonary reactions, including dyspnea, chest pain, alveolar infiltrates May cause pulmonary reactions, including dyspnea, chest pain, alveolar infiltrates May produce harmless brown color in urine May produce harmless brown color in urine Contraindicated in clients with renal impairment Contraindicated in clients with renal impairment

ADULT HEALTH: Renal Medications Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc.62-4 PYRAMID POINTS II. Fluoroquinolones  Description Suppress bacterial growth by inhibiting an enzyme necessary for DNA synthesis Suppress bacterial growth by inhibiting an enzyme necessary for DNA synthesis Are active against a broad spectrum of microbes Are active against a broad spectrum of microbes  Side effects and nursing considerations Administer with full glass of water Administer with full glass of water Ensure maintenance of urine output of at least 1200 to 1500 mL/day Ensure maintenance of urine output of at least 1200 to 1500 mL/day Advise client to report dizziness, visual disturbances, photophobia, feelings of depression Advise client to report dizziness, visual disturbances, photophobia, feelings of depression Instruct client of signs of hepatic, renal toxicity; if they occur, report to physician Instruct client of signs of hepatic, renal toxicity; if they occur, report to physician

ADULT HEALTH: Renal Medications Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc.62-5 PYRAMID POINTS III. Sulfonamides  Description Suppress bacterial growth Suppress bacterial growth Are active against a broad spectrum of microbes Are active against a broad spectrum of microbes Are used primarily to treat acute urinary tract infections Are used primarily to treat acute urinary tract infections  Side effects and nursing considerations Should be discontinued if rash is noted Should be discontinued if rash is noted Instruct client to complete entire course of antibiotics prescribed Instruct client to complete entire course of antibiotics prescribed Adults should maintain urine output of 1200 mL/day Adults should maintain urine output of 1200 mL/day IV doses should be administered over IV doses should be administered over 60 to 90 minutes, not mixed with other medications

ADULT HEALTH: Renal Medications Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc.62-6 PYRAMID POINTS IV. Urinary Tract Analgesic  Description Administered with an antibiotic Administered with an antibiotic  Side effects Nausea Nausea Headache Headache Vertigo Vertigo  Nursing considerations Instruct client that urine will turn red or orange Instruct client that urine will turn red or orange

ADULT HEALTH: Renal Medications Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc.62-7 PYRAMID POINTS V. Anticholinergics and Antispasmodics  Description Relax smooth muscles of the urinary tract Relax smooth muscles of the urinary tract Decrease bladder muscle spasms Decrease bladder muscle spasms Reduce urinary incontinence, urgency, and frequency by controlling bladder contractions Reduce urinary incontinence, urgency, and frequency by controlling bladder contractions  Side effects Anticholinergic effects Anticholinergic effects Dizziness Dizziness Drowsiness Drowsiness  Nursing considerations Do not administer oxybutynin (Ditropan) to clients with known hypersensitivity, gastrointestinal or genitourinary obstruction, glaucoma, severe colitis, myasthenia gravis Do not administer oxybutynin (Ditropan) to clients with known hypersensitivity, gastrointestinal or genitourinary obstruction, glaucoma, severe colitis, myasthenia gravis Monitor for signs of toxicity Monitor for signs of toxicity

ADULT HEALTH: Renal Medications Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc.62-8 PYRAMID POINTS VI. Cholinergic Medications  Description Increase bladder tone and function Increase bladder tone and function  Side effects Headache Headache Hypotension Hypotension Flushing and sweating Flushing and sweating Abdominal cramps Abdominal cramps Urinary urgency Urinary urgency  Nursing considerations Do not administer if client has urinary stricture or obstruction Do not administer if client has urinary stricture or obstruction Monitor intake and output Monitor intake and output Monitor for cholinergic overdose (excessive salivation, sweating, involuntary urination and defecation, bradycardia, and severe hypotension) Monitor for cholinergic overdose (excessive salivation, sweating, involuntary urination and defecation, bradycardia, and severe hypotension)

ADULT HEALTH: Renal Medications Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc.62-9 PYRAMID POINTS VII. Medications for Prevention of Organ Rejection  Include immunosuppressants, corticosteroids, cytoxic medications, antibodies

ADULT HEALTH: Renal Medications Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc PYRAMID POINTS VII. Medications for Prevention of Organ Rejection (continued)  Cyclosporine (Sandimmune, Gengraf, Neoral) Most common adverse effects are nephrotoxicity, infection, hypertension, tremor, hirsutism Most common adverse effects are nephrotoxicity, infection, hypertension, tremor, hirsutism Client should be instructed to monitor for early signs of infection; report immediately Client should be instructed to monitor for early signs of infection; report immediately Instruct client to dispense oral liquid medication into glass container using specially calibrated pipette, mix well, drink immediately, rinse glass container with diluent, drink to ensure ingestion of complete dose Instruct client to dispense oral liquid medication into glass container using specially calibrated pipette, mix well, drink immediately, rinse glass container with diluent, drink to ensure ingestion of complete dose Instruct client to mix medication with milk, chocolate milk, orange juice just before administration Instruct client to mix medication with milk, chocolate milk, orange juice just before administration

ADULT HEALTH: Renal Medications Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc PYRAMID POINTS VII. Medications for Prevention of Organ Rejection (continued)  Sirolimus (Rapamune) Increases risk of infection, renal injury, lymphocele, raises cholesterol, triglyceride levels Increases risk of infection, renal injury, lymphocele, raises cholesterol, triglyceride levels  Tacrolimus (Prograf) Adverse effects include nephrotoxicity, infection, hypertension, tremor, neurotoxicity, hyperkalemia Adverse effects include nephrotoxicity, infection, hypertension, tremor, neurotoxicity, hyperkalemia  Prednisone (Deltasone) Hyperglycemia, hypokalemia can occur Hyperglycemia, hypokalemia can occur  Azathioprine (Imuran) Can cause neutropenia, thrombocytopenia Can cause neutropenia, thrombocytopenia

ADULT HEALTH: Renal Medications Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc PYRAMID POINTS VII. Medications for Prevention of Organ Rejection (continued)  Mycophenolate mofetil (CellCept) Major adverse effects include diarrhea, severe neutropenia, vomiting, sepsis Major adverse effects include diarrhea, severe neutropenia, vomiting, sepsis  Daclizumab (Zenapax), basiliximab (Simulect) Contraindicated in clients with allergy to protein Contraindicated in clients with allergy to protein  Antithymocyte globulin, equine (Atgam) Before first infusion, client should undergo intradermal skin test for hypersensitivity Before first infusion, client should undergo intradermal skin test for hypersensitivity  Muromonab-CD3 (Orthoclone OKT3) Adverse reactions include fever, chills, dyspnea, chest pain Adverse reactions include fever, chills, dyspnea, chest pain

ADULT HEALTH: Renal Medications Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc PYRAMID POINTS VIII. Hematopoietic Growth Factors  Erythropoietic growth factors Major side effect is hypertension Major side effect is hypertension  Leukopoietic growth factors Can cause bone pain, leukocytosis, elevation of plasma uric acid, lactate dehydrogenase, alkaline phosphatase levels Can cause bone pain, leukocytosis, elevation of plasma uric acid, lactate dehydrogenase, alkaline phosphatase levels  Thrombopoietic growth factor Adverse effects include fluid retention, cardiac dysrhythmias, conjunctival infections, visual blurring, papilledema Adverse effects include fluid retention, cardiac dysrhythmias, conjunctival infections, visual blurring, papilledema

ADULT HEALTH: Renal Medications Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc A client must begin medication therapy with mycophenolate mofetil (CellCept) to prevent organ rejection following renal transplantation. The nurse plans to teach the client which of the following teaching points? 1. Notify the physician if a fever develops. 2. Take the medication with an aluminum-based antacid. 3. Take the dose following meals. 4. Open the capsule and mix with food before use.